NASDAQ · LGND

Ligand Pharmaceuticals Inc

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 −37
  • account_balance
    229 funds bought, 134 sold in the quarter ended Jun 30, 2026. 101 were new holders.
  • info
    4 real insider sales in 12 months. $1.73M in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

418 funds report owning LGND, up from 360

Holdings as of Jun 30, 2026
New101
Added128
Held98
Trimmed91
Sold out43

Last quarter

Who bought and who sold

BlackRock, Inc.
+5%
Invesco Ltd.
+46%
Vanguard Portfolio Management LLC
+3%
Jupiter Topco LLC
New
Vanguard Capital Management LLC
+3%
State Street Corp
+6%
FMR LLC
+28%
Franklin Resources Inc
+31%

Change in shares held, biggest holdings first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOption exercise · Nov 2 · $261KPlanned sale (10b5-1) · Nov 2 · $1.57MOpen-market sale · Oct 30 · $452KOpen-market sale · Nov 2 · $224KOpen-market sale · Nov 4 · $90.2KOpen-market sale · Nov 10 · $960K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOption exercise · Nov 2 · $261KPlanned sale (10b5-1) · Nov 2 · $1.57MOpen-market sale · Oct 30 · $452KOpen-market sale · Nov 2 · $224KOpen-market sale · Nov 4 · $90.2KOpen-market sale · Nov 10 · $960K

Last 6 months. A wider screen shows 12.

Showing 4 real trades. Hidden: 1 option exercise, 1 planned 10b5-1 sale. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Nov 10 Jason Aryeh Director Open-market sale $960K 3,000 sh at $320.05
Nov 4 Jason Aryeh Director Open-market sale $90.2K 282 sh at $319.99
Nov 2 Jason Aryeh Director Open-market sale $224K 700 sh at $320.43
Oct 30 Jason Aryeh Director Open-market sale $452K 1,411 sh at $320.24

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Congress · last 12 months

Members of Congress who traded LGND

All Congress trades
LGND Ligand Pharmaceuticals Incorporated - Common Stock Gilbert Cisneros CA-31 Purchase $1,001 – $15,000 Traded May 29, 2026 Reported Jun 8, 2026
LGND Ligand Pharmaceuticals Incorporated - Common Stock Gilbert Cisneros CA-31 Purchase $1,001 – $15,000 Traded Mar 3, 2026 Reported Apr 7, 2026
LGND Ligand Pharmaceuticals Incorporated - Common Stock Gilbert Cisneros CA-31 Purchase $1,001 – $15,000 Traded Jan 15, 2026 Reported Feb 13, 2026
LGND Ligand Pharmaceuticals Incorporated - Common Stock Gilbert Cisneros CA-31 Purchase $1,001 – $15,000 Traded Jan 5, 2026 Reported Feb 13, 2026

Amounts are the ranges members report, not exact amounts. Reports can come up to 45 days after the trade. From House STOCK Act reports. This is data, not advice.

Top holders

Biggest funds in LGND

As of Jun 30, 2026
FundValueChange
BlackRock, Inc.$980M+5%
Invesco Ltd.$380M+46%
Vanguard Portfolio Management LLC$360M+3%
Jupiter Topco LLC$329MNew
Vanguard Capital Management LLC$275M+3%

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk.

This is data, not investment advice. About StockToast